Latest News in the pharma Industry
Research & Development
Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab
13 Nov 2014
Read more
First Wave of Phase III Development Programme for Grazoprevir/Elbasvir is Fully Enrolled; Merck Plans to Submit NDA in 2015
13 Nov 2014
Read more
Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase III Study Of Brodalumab
12 Nov 2014
Read more
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma
11 Nov 2014
Read more